Koyfin Home > Directory > Health Care > Anika Therapeutics > Altman Z-score

Anika Therapeutics Altman Z-score Chart (ANIK)

Anika Therapeutics annual/quarterly Altman Z-score from 2010 to 2020.
  • Anika Therapeutics Altman Z-score for the quarter ending June 06, 2020 was 3.32 a -321.81% decrease of -10.69 year over year
  • Anika Therapeutics Altman Z-score for the last 12 months ending June 06, 2020 was 4.30 a -166.19% decrease of -7.15 year over year
  • Anika Therapeutics Annual Altman Z-score for 2019 was 11.58 a -134.56% decrease of -15.58 from 2018
  • Anika Therapeutics Annual Altman Z-score for 2018 was 27.15 a 4.65% increase of 1.26 from 2017
  • Anika Therapeutics Annual Altman Z-score for 2017 was 25.89 a -0.07% decrease of -0.02 from 2016
Other Balance Sheet Metrics:
  • Anika Therapeutics Total Assets for the quarter ending December 12, 2018 was $279m a -1.92% decrease of -5m year over year
  • Anika Therapeutics Other Liabilities for the quarter ending December 12, 2018 was $4m a -57.58% decrease of -2m year over year
  • Anika Therapeutics Total Equity for the quarter ending December 12, 2018 was $264m a -0.06% decrease of 0m year over year
View Chart On Koyfin

Quarterly ANIK Altman Z-score Data

06/20203.32
03/20205.11
12/201914.13
09/201914.01
06/201911.39
03/201910.12
12/201822.87
09/201827.34
06/201822.06
03/201826.18

Annual ANIK Altman Z-score Data

201911.58
201827.15
201725.89
201625.91
201515.84
201427.19
201310.38
20125.07
20113.20
20102.40